United States Neonatal and Prenatal Devices Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)

United States Neonatal and Prenatal Devices Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)

The US neonatal and prenatal devices market is expected to register a CAGR of 7.1% during the forecast period.

The PubMed data published in April 2021 concluded that compared to mothers who were COVID-19 negative, SARS-CoV-2 infection increased the odds of preterm birth and iatrogenic preterm delivery was more common in infected women. Thus, the association of COVID-19 with preterm birth impacted the market for fetal and neonatal devices. However, the market studied has re-gained its pre-pandemic demand in 2022 with the decrease in COVID-19 infections.

The major factors for the growth of the neonatal and prenatal devices market include the rising incidence of preterm births, increasing awareness for prenatal and neonatal care, and government initiatives to provide better care for prenatal and neonatal infants. Premature babies are babies born before the mother reaches the gestation period of 37 weeks. In United States, preterm birth is the leading cause of mortality among children, accounting for 18% of all deaths among children under the age of 5 and up to 35% of all deaths among infants (aged 28 days), with 1 million children dying before reaching the age of 5, as stated by the PubMed data published in 2021. Hence, high mortality due to preterm birth is expected to fuel growth in the market, as neonatal devices can be used to reduce mortality among preterm babies.

Apart from that, several maternal factors, like early or late pregnancy, drug addiction cases, diabetes, hypertension, bleeding, sexually transmitted diseases, and multiple pregnancies, among others, raise the importance and demand for fetal and neonatal monitoring devices. These are expected to drive growth in the market studied. For instance, preterm birth is associated with an increased risk of type 1 and type 2 diabetes from childhood, and children may need early preventive evaluation and long-term monitoring for diabetes.

Therefore, due to the above-mentioned factors, the US neonatal and prenatal devices market is expected to grow during the forecast period.

Neonatal monitoring is one of the crucial aspects of neonatal care. With an increasing burden of preterm births and the complications associated with the newborn in United States, neonatal monitoring has become important. The monitoring devices for newborns include heart rate monitors, respiratory monitors, temperature monitors, and uterine contraction monitors, among others.

A heart rate monitor is one of the most used neonatal monitoring devices. Prenatal heart rate monitoring devices are used to check the condition of a fetus during labor and delivery by monitoring the fetus's heart rate with special equipment, external and internal. Heart rate monitors can help detect changes in the normal heart rate pattern during labor and are crucial in monitoring preterm birth babies during a high-risk pregnancy. With the rising number of preterm births and high-risk pregnancies, the use and demand for fetal heart rate monitors are expected to increase, likely boosting the segment's growth.

The major factors responsible for the increasing use of fetal heart rate monitors are increasing high-risk pregnancies and preterm births, which require continuous monitoring of the fetus for a healthy delivery. Thus, the heart rate monitor segment is expected to grow over the forecast period. With the technological advancement in heart rate monitors, new product launches, and increasing awareness among expectant mothers, the market is expected to grow during the forecast period. For instance, in May 2021, Medtronic plc announced the U.S. commercial launch of the SonarMed airway monitoring system. With the launch of such innovative devices by key companies, the segment is believed to witness strong growth over the forecast period.

Fetal pulse oximeters are gaining attention in neonatal and prenatal care as diseases, such as pneumonia, are rising. As United States owns one of the most well-established healthcare systems, there is a presence of technologically advanced fetal oximeter manufacturers in the country, which is a crucial factor for market growth.

According to the November 2021 report of the National Cancer Institute of United States, about 15,590 children, including newborns, were diagnosed with cancer, and 1,780 died of the disease in United States in 2021. Among children aged 0 to 14 years, approximately 10,500 were diagnosed with cancer. Thus, the prevalence of cancer among children is further expected to fuel growth in the market studied during the forecast period.

Furthermore, new product launches in the segment are expected to propel the growth. For instance, in January 2022, the UC Davis lab in United States developed a fetal oximetry device to prevent unnecessary C-sections. UC Davis stated during the launch that Fetal Hypoxia is a condition that occurs when the fetus is deprived of an adequate supply of oxygen, which is one reason obstetricians may perform a Caesarean section (C-section). With the help of a pulse oximeter from UC Davis, several C-section surgeries can be avoided, as stated by the company.

Additionally, in November 2021, Masimo Corporation, a US-based company, launched Dual SET Pulse Oximetry, a highly versatile patient monitoring and connectivity hub. Dual SET Oximetry is a significant advancement to Masimo SET guided critical congenital heart disease (CCHD) screening. Hence, the segment is expected to witness substantial growth during the forecast period owing to such launches.

The US neonatal and prenatal devices market is moderately competitive, with the presence of various global companies and a few local companies in the country. With the help of innovation, major players are coming up with strategies such as new product launches and partnerships to fulfill the increasing demand for neonatal and prenatal devices. Some of the key players in the market include Natus Medical Incorporated, GE Healthcare, Getinge AB, Medtronic PLC, and Koninklijke Philips NV, among others.

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support